PFE Stock Continues To Drop As Lung Cancer Trial Disappointment Overshadows Ibrance Win
The U.S. Food and Drug Administration approved the use of Ibrance as maintenance treatment for adults with a specific type of advanced or metastatic breast cancer on Wednesday.
Stocktwits
More News
GOOGL Stock: Google Loses More AI Talent As Two Experts Reportedly Move To Anthropic
Alphabet Inc.’s Google is facing an intensifying talent drain after two more high-profile artificial intelligence researchers decided to jump ship to competitor Anthropic PBC.
Stocktwits
TSLA Stock Holds Flat — Tesla Hit With Wrongful Death Lawsuit, NTSB Probe Over Fatal Texas Crash
The family of the 76-year-old woman killed when a Tesla Model 3 plowed into their suburban Houston home has filed a wrongful death lawsuit against Tesla and the driver, NBC News reported.
Stocktwits
Higher S&P 500 Forecasts Signal Buying Opportunity: ETFs to Consider
Markets remain volatile, but rising forecasts suggest opportunities for long-term ETF investors.
Zacks
The Vanguard ETF That Could Set You Up for Life if You Buy It Today
Key PointsThe Vanguard S&P 500 ETF (VOO) contains around 500 of the largest public American companies...
Nasdaq News: Markets
The Market Is Up 10% in 2026 -- Are These ETFs Still Worth Buying Now?
Key PointsThe Vanguard S&P 500 ETF is a great core ETF to own...
Nasdaq News: Markets
FDX Stock Drops Over 5% As Weak Guidance Overshadows Post-Spin-Off Earnings Win
FedEx reported Q4 earnings and revenue that beat Wall Street expectations.
Stocktwits
S&P 500, Nasdaq, Dow Drop As Broader Tech And AI Selloff Continues — SPCX, BLZE, WMT, WEN, MU In Focus
Chipmaker stocks led declines on Tuesday, tracking broader tech weakness in Asian stocks, particularly South Korean equities.
Stocktwits
TSLA Stock: Tesla Doubles EU Registrations In May But BYD Still Leads With Over 26K Units
Tesla registered 21,767 new passenger cars last month in the EU, compared to 8,623 units in May 2025, according to data from the European Automobile Manufacturers’ Association (ACEA).
Stocktwits
TSLA Stock Falls 6% As Q2 Delivery Optimism Collides With FSD Safety Probe
Wall Street analysts are raising their estimates for the second quarter, pointing to improving sales trends in key markets while noting Tesla’s strategic pivot away from traditional vehicle production.